<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03601221</url>
  </required_header>
  <id_info>
    <org_study_id>HEV-TI-2018</org_study_id>
    <nct_id>NCT03601221</nct_id>
  </id_info>
  <brief_title>Seroprevalence Hepatitis E Infection in Healthy Blood Donors</brief_title>
  <official_title>Observational Study on Seroprevalence of Hepatitis E Infection in Healthy Blood Donors in the Canton Ticino</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ente Ospedaliero Cantonale, Bellinzona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Transfusion SRC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Trial Unit Ente Ospedaliero Cantonale</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ente Ospedaliero Cantonale, Bellinzona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a HEV seroprevalence in the health donors in the Canton Ticino study. The
      pre-donation sampling pouch of each blood donor coming form the Cantone Ticino region will be
      collected and tested for HEV serology (IgM and IgG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-donation sampling pouch of fresh and stored frozen plasma collected within the last 5
      years will be tested for HEV IgG serology at the National Reference Laboratory of the Blood
      Transfusion Services SRC in Berne Collected data will be used to determine HEV
      seroprevalence, actual and in the last 5 years, in the Canton Ticino and to investigate trend
      and pattern of the HEV infection (seroprevalence by different regional areas, comparison with
      national HEV data, and correlation with age, sex and place of residence).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 29, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HEV blood incidence</measure>
    <time_frame>One year</time_frame>
    <description>HEV incidence assessed through a single periferal blood sample from each donor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in the blood incidence of HEV</measure>
    <time_frame>Five years</time_frame>
    <description>Determine the change in the incidence of HEV in the Canton Ticino region in the last 5 years analysing the blood sample of the donors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geogarphical distribution of the HEV measured in the blood sample</measure>
    <time_frame>Five years</time_frame>
    <description>Determination of the distribution of the HEV infection in different geographical areas of the Canton Ticino analysing donor blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trend of the HEV infection measured in the blood sample</measure>
    <time_frame>One year</time_frame>
    <description>Evaluation of the trend of the HEV infection in the CantoneTicino compared to other Swiss cantons</description>
  </secondary_outcome>
  <enrollment type="Actual">1447</enrollment>
  <condition>Hepatitis E</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sample collection</intervention_name>
    <description>Collection of one sampling pouch from each blood donor</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy and voluntary blood donors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy and voluntary blood donors

          -  Subjects living in the Canton Ticino

          -  Inclusion criteria for blood donation

          -  Signed informed consent of the STCRS SI for blood donation

        Exclusion Criteria:

          -  Exclusion criteria for blood donation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Florian Bihl, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ente Ospedaliero Cantonale, Bellinzona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Swiss Transfusion SRC Canton Ticino</name>
      <address>
        <city>Lugano,</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis E</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

